Author

Alessandro Federico

RISK FACTORS FOR LIVER DECOMPENSATION AND HCC IN HCV-CIRRHOTIC PATIENTS AFTER DAAS: A MULTICENTER PROSPECTIVE STUDY
RISK FACTORS FOR LIVER DECOMPENSATION AND HCC IN HCV-CIRRHOTIC PATIENTS AFTER DAAS: A MULTICENTER PROSPECTIVE STUDY

Alessandro Federico  et al.

ASSESSMENT OF PHYSICAL ACTIVITY LEVELS AND ITS BARRIERS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: THE “BE-FIT-IBD” STUDY RESULTS IN SOUTHERN EUROPE
ASSESSMENT OF PHYSICAL ACTIVITY LEVELS AND ITS BARRIERS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: THE “BE-FIT-IBD” STUDY RESULTS IN SOUTHERN EUROPE

Alessandro Federico  et al.

BNT162B2 MRNA COVID-19 VACCINE SAFETY IN INFLAMMATORY BOWEL DISEASE PATIENTS ON BIOLOGIC THERAPY: A MONOCENTRIC REAL-WORLD STUDY
BNT162B2 MRNA COVID-19 VACCINE SAFETY IN INFLAMMATORY BOWEL DISEASE PATIENTS ON BIOLOGIC THERAPY: A MONOCENTRIC REAL-WORLD STUDY

Alessandro Federico  et al.

THE INFLUENCE OF GENETIC VARIANTS PNPLA3, TM6SF2, AND MBOAT7 ON THE RESPONSE TO A SILYBIN/VITAMIN D-BASED TREATMENT FOR METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE PATIENTS
THE INFLUENCE OF GENETIC VARIANTS PNPLA3, TM6SF2, AND MBOAT7 ON THE RESPONSE TO A SILYBIN/VITAMIN D-BASED TREATMENT FOR METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE PATIENTS

Alessandro Federico  et al.

HOW HAS THE SEVERE-ACUTE-RESPIRATORY-SYNDROME CORONAVIRUS 2 PANDEMIC AFFECTED ALCOHOL CONSUMPTION? A NATIONAL SURVEY FOR THE ASSESSMENT OF ALCOHOL DRINKING HABITS IN A SAMPLE OF ITALIAN CITIZENS DURING LOCKDOWN
HOW HAS THE SEVERE-ACUTE-RESPIRATORY-SYNDROME CORONAVIRUS 2 PANDEMIC AFFECTED ALCOHOL CONSUMPTION? A NATIONAL SURVEY FOR THE ASSESSMENT OF ALCOHOL DRINKING HABITS IN A SAMPLE OF ITALIAN CITIZENS DURING LOCKDOWN

Alessandro Federico  et al.

HEPATOBILIARY DISORDERS IN INFLAMMATORY BOWEL DISEASE: WHAT COULD BE THE OPTIMAL MANAGEMENT WHEN PRIMARY BILIARY CHOLANGITIS PRECEDES THE ONSET OF CROHN ILEITIS? A SIXTY-SIX YEARS OLD FEMALE PATIENT CASE REPORT
HEPATOBILIARY DISORDERS IN INFLAMMATORY BOWEL DISEASE: WHAT COULD BE THE OPTIMAL MANAGEMENT WHEN PRIMARY BILIARY CHOLANGITIS PRECEDES THE ONSET OF CROHN ILEITIS? A SIXTY-SIX YEARS OLD FEMALE PATIENT CASE REPORT

Alessandro Federico  et al.

ASSESSMENT OF URINARY VOLATILE ORGANIC COMPOUNDS: A NON-INVASIVE TOOL FOR DISCRIMINATION OF TYPE 2 DIABETES MELLITUS (T2DM) AND METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE (MAFLD)-FREE T2DM
ASSESSMENT OF URINARY VOLATILE ORGANIC COMPOUNDS: A NON-INVASIVE TOOL FOR DISCRIMINATION OF TYPE 2 DIABETES MELLITUS (T2DM) AND METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE (MAFLD)-FREE T2DM

Alessandro Federico  et al.

THE UROTENSIN-II RECEPTOR: A NEW PREDICTIVE MARKER OF STAGING OF ULCERATIVE COLITIS AND THERAPEUTIC RESPONSE TO INTRAVENOUS STEROID ADMINISTRATION
THE UROTENSIN-II RECEPTOR: A NEW PREDICTIVE MARKER OF STAGING OF ULCERATIVE COLITIS AND THERAPEUTIC RESPONSE TO INTRAVENOUS STEROID ADMINISTRATION

Alessandro Federico  et al.

SYSTEMIC OXIDATIVE STRESS-UNBALANCE IN PBC PATIENTS: A PRELIMINARY OBSERVATION ON CORRELATION WITH LIVER DISEASE PROGRESSION
SYSTEMIC OXIDATIVE STRESS-UNBALANCE IN PBC PATIENTS: A PRELIMINARY OBSERVATION ON CORRELATION WITH LIVER DISEASE PROGRESSION

Alessandro Federico  et al.

A MULTICENTER CLINICAL STUDY ON SARS-COV2 PANDEMIC CONFINEMENT: A FORCED IN VIVO TEST OF SHORT-TERM LIFESTYLE CHANGES AND THE INFLUENCE ON METABOLIC- (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE (MAFLD) EVOLUTION
A MULTICENTER CLINICAL STUDY ON SARS-COV2 PANDEMIC CONFINEMENT: A FORCED IN VIVO TEST OF SHORT-TERM LIFESTYLE CHANGES AND THE INFLUENCE ON METABOLIC- (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE (MAFLD) EVOLUTION

Alessandro Federico  et al.

VEDOLIZUMAB AS RESCUE THERAPY FOR ACUTE SEVERE ULCERATIVE COLITIS INDUCED BY SECOND-LINE CHEMOTHERAPY FOR RECURRENCE OF PLEOMORPHIC LUNG CARCINOMA
VEDOLIZUMAB AS RESCUE THERAPY FOR ACUTE SEVERE ULCERATIVE COLITIS INDUCED BY SECOND-LINE CHEMOTHERAPY FOR RECURRENCE OF PLEOMORPHIC LUNG CARCINOMA

Alessandro Federico  et al.

ENVIRONMENTAL BISPHENOL A EXPOSURE INFLUENCES TRAINED IMMUNITY-RELATED PATHWAYS IN NON-ALCOHOLIC FATTY LIVER DISEASE: A PRELIMINARY OBSERVATION
ENVIRONMENTAL BISPHENOL A EXPOSURE INFLUENCES TRAINED IMMUNITY-RELATED PATHWAYS IN NON-ALCOHOLIC FATTY LIVER DISEASE: A PRELIMINARY OBSERVATION

Alessandro Federico  et al.

ADVANCED FIBROSIS AND CARDIOVASCULAR RISK PREDICTION IN MAFLD: THE ALPHA-GLUTATHIONE-S-TRANSFERASE (ALPHAGST) AND THE “METABOLIC ABNORMALITIES-AST/PLATELET RATIO- INFLAMMATION-ALPHAGST LEVELS” (MARINA) INDEX AS A NOVEL PREDICTIVE BIOMARKER AND COMPOSITE T
ADVANCED FIBROSIS AND CARDIOVASCULAR RISK PREDICTION IN MAFLD: THE ALPHA-GLUTATHIONE-S-TRANSFERASE (ALPHAGST) AND THE “METABOLIC ABNORMALITIES-AST/PLATELET RATIO- INFLAMMATION-ALPHAGST LEVELS” (MARINA) INDEX AS A NOVEL PREDICTIVE BIOMARKER AND COMPOSITE T

Alessandro Federico  et al.

THE INFLUENCE OF SUPERIMPOSED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-COV-2) LIFESTYLE CHANGES ON METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE (MAFLD) EVOLUTION: A MATTER OF BODY COMPOSITION
THE INFLUENCE OF SUPERIMPOSED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-COV-2) LIFESTYLE CHANGES ON METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE (MAFLD) EVOLUTION: A MATTER OF BODY COMPOSITION

Alessandro Federico  et al.

USING A JAK-STAT INHIBITOR IN MODERATE-SEVERE ULCERATIVE COLITIS ASSOCIATED WITH HIDRADENITIS SUPPURATIVA: PROBABLY NOT A FAUX PAS!
USING A JAK-STAT INHIBITOR IN MODERATE-SEVERE ULCERATIVE COLITIS ASSOCIATED WITH HIDRADENITIS SUPPURATIVA: PROBABLY NOT A FAUX PAS!

Alessandro Federico  et al.

ANTI-INFLAMMATORY EFFECTS OF HERICIUM ERINACEUS, BERBERINE, QUERCETIN, BIOTIN, AND NIACIN (HBQ-COMPLEX®) IN CROHN’S DISEASE AND ULCERATIVE COLITIS: AN EX VIVO TISSUE MODEL STUDY
ANTI-INFLAMMATORY EFFECTS OF HERICIUM ERINACEUS, BERBERINE, QUERCETIN, BIOTIN, AND NIACIN (HBQ-COMPLEX®) IN CROHN’S DISEASE AND ULCERATIVE COLITIS: AN EX VIVO TISSUE MODEL STUDY

Alessandro Federico  et al.

HEPATOCELLULAR CARCINOMA (HCC) OCCURRENCE IN A LYSOSOMAL ACID LIPASE DEFICIENCY (LALD)-AFFECTED 49-YEARS OLD NON-CIRRHOTIC MALE: HOW TO MANAGE THE MALIGNANCY IN THIS RARE LIVER-DISEASE CONTEXT?
HEPATOCELLULAR CARCINOMA (HCC) OCCURRENCE IN A LYSOSOMAL ACID LIPASE DEFICIENCY (LALD)-AFFECTED 49-YEARS OLD NON-CIRRHOTIC MALE: HOW TO MANAGE THE MALIGNANCY IN THIS RARE LIVER-DISEASE CONTEXT?

Alessandro Federico  et al.

IL-6 INHIBITOR AS PALLIATIVE TREATMENT FOR A 63 YEARS-OLD MALE PATIENT SUFFERING STAUFFER’S SYNDROME-RELATED PARANEOPLASTIC CHOLESTASIS
IL-6 INHIBITOR AS PALLIATIVE TREATMENT FOR A 63 YEARS-OLD MALE PATIENT SUFFERING STAUFFER’S SYNDROME-RELATED PARANEOPLASTIC CHOLESTASIS

Alessandro Federico  et al.

INTESTINAL PSEUDO-OBSTRUCTION AS A COMPLICATION OF SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT OF A FORTY-FOUR YEARS OLD MALE PATIENT WITH RECURRENT GI OBSTRUCTIVE SYMPTOMS
INTESTINAL PSEUDO-OBSTRUCTION AS A COMPLICATION OF SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT OF A FORTY-FOUR YEARS OLD MALE PATIENT WITH RECURRENT GI OBSTRUCTIVE SYMPTOMS

Alessandro Federico  et al.

NAVIGATING IRRITABLE BOWEL SYNDROME EPIDEMIOLOGY AND BURDEN IN MEDICAL AND NURSE STUDENTS IN THE “VANVITELLI-IBS STUDY”: GOOD ANXIETY CONTROL AND ADHERENCE TO THE MEDITERRANEAN DIET AS POSSIBLE PROTECTIVE FACTORS
NAVIGATING IRRITABLE BOWEL SYNDROME EPIDEMIOLOGY AND BURDEN IN MEDICAL AND NURSE STUDENTS IN THE “VANVITELLI-IBS STUDY”: GOOD ANXIETY CONTROL AND ADHERENCE TO THE MEDITERRANEAN DIET AS POSSIBLE PROTECTIVE FACTORS

Alessandro Federico  et al.

Item 1 - 20 / 22
1
2